Dosage & Administration Efficacy safety testing Drug label Prior authorization Financial assistance

Leukine

(sargramostim)

sargramostim 0.25 MG/ML Injectable Solution [Leukine]

NO BLACK BOX WARNING

Dosage & administration

See Full Prescribing Information for dosage adjustments and timing of administration .

* AML, Neutrophil recovery following chemotherapy:
* 250 mcg/m2/day administered intravenously over a 4-hour period.

* Mobilization of peripheral blood progenitor cells:
* 250 mcg/m2/day administered intravenously over 24 hours or subcutaneous injection once daily.

* Post peripheral blood progenitor cell transplantation:
* 250 mcg/m2/day administered intravenously over 24 hours or subcutaneous injection once daily.

* Myeloid reconstitution after autologous or allogeneic BMT:
* 250 mcg/m2/day administered intravenously over a 2-hour period.

* BMT failure or engraftment delayed:
* 250 mcg/m2/day for 14 days as a 2-hour intravenous infusion.

* Patients acutely exposed to myelosuppressive doses of radiation, administer once daily as subcutaneous injection:
* Adults and pediatric patients weighing >40 kg: 7 mcg/kg
* Pediatric patients 15 kg to 40 kg: 10 mcg/kg
* Pediatric patients <15 kg: 12 mcg/kg

eficacy, safety & testing

Leukine clinical details

Mechanism of Action (MOA)

Efficacy

drug label

Leukine prescribing information

Have more Leukine questions?

Submit MSL Request

Learn More

Need to report a Leukine issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Leukine Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

LeukineDirect Patient Enrollment Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Leukine Financial assistance options

Co-pay savings program

commercial only

LeukineDirect Patient Enrollment Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

LeukineDirect Patient Assistance Program Application

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Leukine Patient education

Getting started on Leukine

NOT PROVIDED BY BRANDInstructions For Use: Bone Marrow Stimulation

Patient toolkit

NOT PROVIDED BY BRANDNot Provided By Brand

Learn More

Leukine FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Leukine

Dosage & administration

eficacy, safety & testing

Leukine clinical details

drug label

Leukine prescribing information

Have more Leukine questions?

Need to report a Leukine issue?

prior authorization

Leukine Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Leukine Financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Leukine Patient education

Getting started on Leukine

Patient toolkit

people also ask

Leukine FAQs

Can't find what you're looking for?